Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Waldenstrom Macroglobulinemia | 247 | 2024 | 1076 | 42.000 |
Why?
|
Myeloid Differentiation Factor 88 | 70 | 2024 | 582 | 13.100 |
Why?
|
Receptors, CXCR4 | 38 | 2024 | 729 | 7.840 |
Why?
|
Adenine | 58 | 2024 | 993 | 7.500 |
Why?
|
Pyrazoles | 47 | 2024 | 2030 | 6.620 |
Why?
|
Piperidines | 60 | 2024 | 1663 | 6.280 |
Why?
|
Pyrimidines | 50 | 2024 | 3043 | 5.930 |
Why?
|
Immunoglobulin M | 64 | 2023 | 1527 | 5.480 |
Why?
|
Protein Kinase Inhibitors | 32 | 2024 | 5690 | 2.910 |
Why?
|
Antineoplastic Agents | 55 | 2023 | 13643 | 2.570 |
Why?
|
Mutation | 59 | 2024 | 30213 | 2.410 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 36 | 2015 | 696 | 2.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 38 | 2021 | 11872 | 2.110 |
Why?
|
Lymphoma, B-Cell | 12 | 2023 | 945 | 1.930 |
Why?
|
Proto-Oncogene Proteins c-hck | 6 | 2024 | 46 | 1.890 |
Why?
|
Antibodies, Monoclonal | 45 | 2021 | 9244 | 1.880 |
Why?
|
Bone Marrow | 22 | 2021 | 2926 | 1.530 |
Why?
|
Boronic Acids | 21 | 2015 | 915 | 1.530 |
Why?
|
Blood Viscosity | 8 | 2019 | 125 | 1.530 |
Why?
|
Pyrazines | 23 | 2021 | 1204 | 1.500 |
Why?
|
B-Lymphocytes | 26 | 2022 | 4784 | 1.480 |
Why?
|
Neoplasm Proteins | 11 | 2021 | 3601 | 1.440 |
Why?
|
Multiple Myeloma | 61 | 2024 | 5194 | 1.390 |
Why?
|
Receptors, IgG | 6 | 2011 | 562 | 1.260 |
Why?
|
Apoptosis | 35 | 2024 | 9513 | 1.200 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2024 | 5329 | 1.170 |
Why?
|
Humans | 331 | 2024 | 766766 | 1.030 |
Why?
|
Antigens, CD20 | 11 | 2019 | 199 | 1.020 |
Why?
|
Quinazolinones | 3 | 2016 | 219 | 1.010 |
Why?
|
Protein-Tyrosine Kinases | 16 | 2017 | 2426 | 1.000 |
Why?
|
Signal Transduction | 41 | 2024 | 23619 | 0.960 |
Why?
|
Plasma Cells | 9 | 2022 | 599 | 0.940 |
Why?
|
Purines | 4 | 2016 | 615 | 0.930 |
Why?
|
Aged | 99 | 2024 | 171343 | 0.920 |
Why?
|
Disease-Free Survival | 20 | 2019 | 6850 | 0.920 |
Why?
|
Antibodies, Neoplasm | 6 | 2011 | 282 | 0.910 |
Why?
|
Aged, 80 and over | 56 | 2024 | 59550 | 0.880 |
Why?
|
Plasmapheresis | 6 | 2017 | 205 | 0.860 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2015 | 176 | 0.850 |
Why?
|
Middle Aged | 105 | 2024 | 223257 | 0.830 |
Why?
|
Lymphoproliferative Disorders | 4 | 2016 | 527 | 0.820 |
Why?
|
Paraproteinemias | 10 | 2017 | 251 | 0.800 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 615 | 0.770 |
Why?
|
Sulfonamides | 4 | 2024 | 1982 | 0.760 |
Why?
|
Lymphoma, Non-Hodgkin | 6 | 2015 | 1374 | 0.750 |
Why?
|
Vidarabine | 6 | 2015 | 342 | 0.730 |
Why?
|
Lymphoma | 6 | 2022 | 1900 | 0.710 |
Why?
|
Antigens, CD | 12 | 2011 | 4032 | 0.700 |
Why?
|
Immunization, Passive | 7 | 2005 | 618 | 0.690 |
Why?
|
Thalidomide | 11 | 2013 | 886 | 0.690 |
Why?
|
Survival Rate | 18 | 2021 | 12825 | 0.690 |
Why?
|
Mutation, Missense | 3 | 2019 | 2590 | 0.690 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2020 | 776 | 0.660 |
Why?
|
Male | 117 | 2024 | 364142 | 0.660 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2019 | 2839 | 0.630 |
Why?
|
Dexamethasone | 17 | 2023 | 1962 | 0.620 |
Why?
|
Amino Acid Substitution | 7 | 2019 | 1742 | 0.610 |
Why?
|
Female | 110 | 2024 | 396520 | 0.610 |
Why?
|
Genomics | 9 | 2024 | 5923 | 0.600 |
Why?
|
Neoplasms, Second Primary | 3 | 2015 | 1061 | 0.600 |
Why?
|
Tumor Cells, Cultured | 39 | 2021 | 6104 | 0.590 |
Why?
|
Retinal Diseases | 3 | 2009 | 709 | 0.570 |
Why?
|
Cell Proliferation | 16 | 2024 | 10445 | 0.560 |
Why?
|
Treatment Outcome | 45 | 2024 | 65273 | 0.550 |
Why?
|
Point Mutation | 3 | 2021 | 1591 | 0.550 |
Why?
|
Sirolimus | 5 | 2015 | 1540 | 0.540 |
Why?
|
Cell Survival | 21 | 2024 | 5748 | 0.530 |
Why?
|
Adult | 67 | 2024 | 223307 | 0.520 |
Why?
|
Nucleosides | 4 | 2010 | 130 | 0.520 |
Why?
|
SEER Program | 4 | 2017 | 1443 | 0.510 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2021 | 1434 | 0.500 |
Why?
|
Cyclophosphamide | 9 | 2023 | 2234 | 0.500 |
Why?
|
Molecular Targeted Therapy | 7 | 2020 | 2823 | 0.500 |
Why?
|
Lung Injury | 1 | 2020 | 432 | 0.490 |
Why?
|
Kaplan-Meier Estimate | 10 | 2020 | 6512 | 0.490 |
Why?
|
Bone Marrow Cells | 10 | 2011 | 2413 | 0.460 |
Why?
|
Immunoglobulin G | 6 | 2016 | 4559 | 0.460 |
Why?
|
Alkylating Agents | 5 | 2017 | 132 | 0.460 |
Why?
|
von Willebrand Factor | 1 | 2018 | 680 | 0.450 |
Why?
|
Drug Tolerance | 1 | 2015 | 365 | 0.450 |
Why?
|
Apoptosis Regulatory Proteins | 6 | 2015 | 1150 | 0.440 |
Why?
|
Warts | 1 | 2013 | 66 | 0.440 |
Why?
|
Glycoproteins | 4 | 2011 | 2201 | 0.440 |
Why?
|
Withholding Treatment | 1 | 2018 | 619 | 0.430 |
Why?
|
Prognosis | 27 | 2024 | 29948 | 0.430 |
Why?
|
Antigens, Neoplasm | 4 | 2011 | 1998 | 0.430 |
Why?
|
Codon, Nonsense | 1 | 2014 | 287 | 0.420 |
Why?
|
Mice, SCID | 15 | 2021 | 2628 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2021 | 1405 | 0.420 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2018 | 627 | 0.420 |
Why?
|
Hydroxamic Acids | 4 | 2013 | 483 | 0.410 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 2002 | 4349 | 0.410 |
Why?
|
Follow-Up Studies | 16 | 2021 | 39309 | 0.410 |
Why?
|
Survival Analysis | 14 | 2020 | 10100 | 0.410 |
Why?
|
Frameshift Mutation | 1 | 2014 | 392 | 0.410 |
Why?
|
Paraproteins | 4 | 2020 | 38 | 0.410 |
Why?
|
Peripheral Nervous System Diseases | 6 | 2017 | 713 | 0.410 |
Why?
|
Disease Progression | 20 | 2021 | 13640 | 0.400 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 17088 | 0.400 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 3 | 2018 | 75 | 0.400 |
Why?
|
Mast Cells | 4 | 2008 | 1405 | 0.390 |
Why?
|
Proto-Oncogene Proteins | 10 | 2015 | 4522 | 0.390 |
Why?
|
NF-kappa B | 13 | 2020 | 2493 | 0.380 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3666 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-akt | 8 | 2018 | 2456 | 0.380 |
Why?
|
Salvage Therapy | 7 | 2018 | 1274 | 0.380 |
Why?
|
Polymorphism, Genetic | 5 | 2011 | 4249 | 0.370 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2011 | 57 | 0.360 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 4 | 2007 | 306 | 0.360 |
Why?
|
Nitrogen Mustard Compounds | 4 | 2015 | 44 | 0.360 |
Why?
|
Antigens, CD19 | 4 | 2024 | 444 | 0.360 |
Why?
|
Polymerase Chain Reaction | 6 | 2015 | 6066 | 0.360 |
Why?
|
Central Nervous System Neoplasms | 2 | 2016 | 926 | 0.350 |
Why?
|
Anemia | 3 | 2011 | 1514 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2018 | 8621 | 0.340 |
Why?
|
Immunologic Factors | 5 | 2014 | 1594 | 0.340 |
Why?
|
Membrane Glycoproteins | 11 | 2016 | 3702 | 0.340 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 548 | 0.340 |
Why?
|
Vincristine | 4 | 2021 | 1039 | 0.330 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2024 | 238 | 0.310 |
Why?
|
Syndrome | 4 | 2018 | 3271 | 0.310 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 350 | 0.310 |
Why?
|
Tunicamycin | 1 | 2008 | 108 | 0.310 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 372 | 0.310 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2011 | 693 | 0.310 |
Why?
|
Lymphocytes | 3 | 2013 | 2605 | 0.310 |
Why?
|
Prospective Studies | 12 | 2023 | 54871 | 0.300 |
Why?
|
Hypergammaglobulinemia | 1 | 2008 | 71 | 0.300 |
Why?
|
Gene Expression Profiling | 13 | 2018 | 9525 | 0.300 |
Why?
|
Agammaglobulinemia | 1 | 2009 | 173 | 0.300 |
Why?
|
Recurrence | 13 | 2015 | 8507 | 0.290 |
Why?
|
Genes, Regulator | 1 | 2009 | 373 | 0.290 |
Why?
|
Interleukin-6 | 15 | 2016 | 3227 | 0.290 |
Why?
|
Boron Compounds | 2 | 2020 | 195 | 0.290 |
Why?
|
Consensus | 8 | 2023 | 3208 | 0.280 |
Why?
|
Flow Cytometry | 13 | 2013 | 5890 | 0.280 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 2 | 2018 | 85 | 0.280 |
Why?
|
Prednisone | 4 | 2021 | 1566 | 0.280 |
Why?
|
Stilbenes | 1 | 2008 | 155 | 0.280 |
Why?
|
Doxorubicin | 6 | 2021 | 2229 | 0.280 |
Why?
|
Gene Expression | 9 | 2019 | 7585 | 0.270 |
Why?
|
Mucin-1 | 3 | 2001 | 536 | 0.270 |
Why?
|
Immunoglobulin A | 3 | 2009 | 992 | 0.270 |
Why?
|
Family Health | 1 | 2011 | 1254 | 0.270 |
Why?
|
Enzyme Inhibitors | 7 | 2011 | 3721 | 0.270 |
Why?
|
Hepatitis C Antibodies | 1 | 2007 | 151 | 0.270 |
Why?
|
Stress, Physiological | 2 | 2011 | 1406 | 0.270 |
Why?
|
Gene Deletion | 2 | 2013 | 2669 | 0.260 |
Why?
|
CD40 Ligand | 4 | 2006 | 528 | 0.260 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2060 | 0.260 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2020 | 370 | 0.260 |
Why?
|
Enzyme Activation | 11 | 2022 | 3587 | 0.260 |
Why?
|
Glycine | 2 | 2020 | 670 | 0.250 |
Why?
|
Simvastatin | 1 | 2008 | 345 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2022 | 5753 | 0.250 |
Why?
|
Cell Adhesion | 7 | 2024 | 3093 | 0.240 |
Why?
|
Leukemia, Myeloid, Acute | 6 | 2009 | 3636 | 0.240 |
Why?
|
Immunophenotyping | 9 | 2019 | 1867 | 0.240 |
Why?
|
Biomedical Research | 2 | 2018 | 3459 | 0.240 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1491 | 0.230 |
Why?
|
Sp1 Transcription Factor | 2 | 2016 | 143 | 0.230 |
Why?
|
Protease Inhibitors | 2 | 2007 | 750 | 0.230 |
Why?
|
Iron | 1 | 2013 | 1812 | 0.230 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2016 | 546 | 0.230 |
Why?
|
Chromosome Deletion | 2 | 2020 | 1384 | 0.230 |
Why?
|
Endoplasmic Reticulum | 2 | 2018 | 1132 | 0.230 |
Why?
|
Retinal Vessels | 2 | 2008 | 863 | 0.230 |
Why?
|
beta 2-Microglobulin | 4 | 2020 | 330 | 0.230 |
Why?
|
Mastocytosis | 1 | 2006 | 150 | 0.220 |
Why?
|
Drug Administration Schedule | 5 | 2011 | 4853 | 0.220 |
Why?
|
MicroRNAs | 6 | 2018 | 3792 | 0.220 |
Why?
|
Mice, Inbred NOD | 5 | 2021 | 1838 | 0.220 |
Why?
|
Stem Cell Transplantation | 5 | 2017 | 1600 | 0.220 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2005 | 266 | 0.210 |
Why?
|
Receptors, IgE | 1 | 2005 | 375 | 0.210 |
Why?
|
Membrane Proteins | 3 | 2016 | 7868 | 0.210 |
Why?
|
Hematocrit | 3 | 2011 | 622 | 0.210 |
Why?
|
Killer Cells, Natural | 4 | 2007 | 2210 | 0.210 |
Why?
|
Leucine | 2 | 2016 | 547 | 0.210 |
Why?
|
DNA-Binding Proteins | 8 | 2014 | 9611 | 0.210 |
Why?
|
Lipopolysaccharides | 5 | 1994 | 2214 | 0.210 |
Why?
|
Transplantation, Heterologous | 7 | 2007 | 2391 | 0.210 |
Why?
|
Proline | 2 | 2016 | 454 | 0.210 |
Why?
|
Clinical Trials as Topic | 7 | 2020 | 8045 | 0.210 |
Why?
|
Epigenomics | 2 | 2020 | 959 | 0.200 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2184 | 0.200 |
Why?
|
Cladribine | 2 | 2015 | 34 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.200 |
Why?
|
Hemoglobins | 5 | 2018 | 1531 | 0.200 |
Why?
|
Neprilysin | 1 | 2005 | 487 | 0.190 |
Why?
|
Interferon-gamma | 6 | 2002 | 3158 | 0.190 |
Why?
|
Myelodysplastic Syndromes | 2 | 2008 | 1404 | 0.190 |
Why?
|
Cyanosis | 1 | 2021 | 82 | 0.190 |
Why?
|
Genetic Linkage | 1 | 2007 | 2342 | 0.190 |
Why?
|
Amyloidosis | 3 | 2004 | 877 | 0.190 |
Why?
|
Immunotherapy | 7 | 2017 | 4747 | 0.180 |
Why?
|
Immunoblotting | 4 | 2012 | 1647 | 0.180 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 1994 | 249 | 0.180 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3824 | 0.180 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2021 | 171 | 0.180 |
Why?
|
Caspase 1 | 1 | 2022 | 227 | 0.180 |
Why?
|
Oligopeptides | 3 | 2015 | 1195 | 0.180 |
Why?
|
Immunotherapy, Active | 1 | 2000 | 58 | 0.180 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2045 | 0.180 |
Why?
|
Transcription Factors | 7 | 2015 | 12150 | 0.180 |
Why?
|
Algorithms | 3 | 2017 | 14072 | 0.180 |
Why?
|
Cell Line | 5 | 2018 | 15563 | 0.180 |
Why?
|
Retrospective Studies | 19 | 2024 | 81635 | 0.170 |
Why?
|
Transplantation, Autologous | 3 | 2022 | 2127 | 0.170 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12534 | 0.170 |
Why?
|
Vasodilator Agents | 1 | 2004 | 988 | 0.170 |
Why?
|
Incidence | 8 | 2018 | 21525 | 0.170 |
Why?
|
Phenotype | 4 | 2016 | 16724 | 0.170 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.170 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 614 | 0.170 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2023 | 180 | 0.170 |
Why?
|
Neoplasms | 5 | 2022 | 22350 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4570 | 0.170 |
Why?
|
Histone Deacetylases | 3 | 2020 | 712 | 0.170 |
Why?
|
Transcriptional Activation | 3 | 2016 | 1749 | 0.170 |
Why?
|
Hepacivirus | 1 | 2007 | 1343 | 0.160 |
Why?
|
Genotype | 5 | 2017 | 13036 | 0.160 |
Why?
|
Acrylamides | 2 | 2018 | 260 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2022 | 2902 | 0.160 |
Why?
|
Integrins | 1 | 2024 | 839 | 0.160 |
Why?
|
Drug Synergism | 6 | 2018 | 1756 | 0.160 |
Why?
|
DNA Mutational Analysis | 3 | 2021 | 4114 | 0.160 |
Why?
|
Disease Management | 3 | 2020 | 2533 | 0.160 |
Why?
|
Models, Biological | 2 | 2014 | 9461 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2020 | 22248 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2015 | 2885 | 0.160 |
Why?
|
Databases, Factual | 1 | 2014 | 8066 | 0.160 |
Why?
|
Portraits as Topic | 1 | 2018 | 33 | 0.160 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 5 | 2002 | 195 | 0.150 |
Why?
|
Registries | 1 | 2014 | 8351 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12985 | 0.150 |
Why?
|
RNA, Viral | 1 | 2007 | 2867 | 0.150 |
Why?
|
Animals | 36 | 2022 | 168930 | 0.150 |
Why?
|
Cytokines | 7 | 2018 | 7438 | 0.150 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2020 | 451 | 0.150 |
Why?
|
Blood Proteins | 2 | 2016 | 1194 | 0.150 |
Why?
|
Estrogen Antagonists | 1 | 1998 | 151 | 0.150 |
Why?
|
Neutropenia | 3 | 2009 | 894 | 0.150 |
Why?
|
Sequence Analysis, DNA | 4 | 2015 | 4780 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9101 | 0.150 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2023 | 2510 | 0.150 |
Why?
|
p21-Activated Kinases | 1 | 2018 | 127 | 0.150 |
Why?
|
Immunoglobulin Light Chains | 3 | 2012 | 289 | 0.140 |
Why?
|
Cells, Cultured | 8 | 2013 | 18984 | 0.140 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 62 | 0.140 |
Why?
|
Patient Care | 1 | 2023 | 629 | 0.140 |
Why?
|
Benzamides | 2 | 2021 | 1375 | 0.140 |
Why?
|
Ophthalmoscopy | 2 | 2009 | 172 | 0.140 |
Why?
|
DNA Methylation | 5 | 2020 | 4427 | 0.140 |
Why?
|
Time Factors | 11 | 2021 | 40149 | 0.140 |
Why?
|
Protein Multimerization | 3 | 2017 | 960 | 0.140 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2018 | 241 | 0.140 |
Why?
|
Aminopyridines | 2 | 2018 | 577 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 583 | 0.140 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2008 | 236 | 0.140 |
Why?
|
Phosphorylation | 13 | 2016 | 8307 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2021 | 3468 | 0.140 |
Why?
|
Mice | 26 | 2022 | 81889 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 329 | 0.140 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1504 | 0.140 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1612 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2019 | 335 | 0.130 |
Why?
|
Inflammasomes | 1 | 2022 | 541 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2021 | 1838 | 0.130 |
Why?
|
Caspases | 4 | 2011 | 881 | 0.130 |
Why?
|
Antimetabolites | 2 | 2014 | 128 | 0.130 |
Why?
|
Hepatitis C | 1 | 2007 | 1595 | 0.130 |
Why?
|
Biopsy | 5 | 2019 | 6779 | 0.130 |
Why?
|
Paracrine Communication | 1 | 2018 | 277 | 0.130 |
Why?
|
Glucuronosyltransferase | 2 | 2008 | 136 | 0.130 |
Why?
|
von Willebrand Diseases | 1 | 2018 | 135 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 8 | 2019 | 18075 | 0.130 |
Why?
|
Chromosome Aberrations | 4 | 2014 | 1776 | 0.130 |
Why?
|
Chemokine CXCL12 | 2 | 2015 | 457 | 0.130 |
Why?
|
Practice Guidelines as Topic | 9 | 2020 | 7431 | 0.130 |
Why?
|
Hematology | 1 | 2019 | 243 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36567 | 0.130 |
Why?
|
Cell Division | 10 | 2000 | 4474 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2015 | 6307 | 0.130 |
Why?
|
Alleles | 3 | 2019 | 6895 | 0.130 |
Why?
|
Glucocorticoids | 3 | 2003 | 2158 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5861 | 0.130 |
Why?
|
Pleural Effusion, Malignant | 1 | 2016 | 108 | 0.120 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6962 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2016 | 697 | 0.120 |
Why?
|
Cyclophilin A | 1 | 2015 | 57 | 0.120 |
Why?
|
Exanthema | 1 | 2019 | 502 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2016 | 527 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18330 | 0.120 |
Why?
|
Octamer Transcription Factor-2 | 1 | 2014 | 7 | 0.120 |
Why?
|
Herpesvirus 8, Human | 4 | 2000 | 254 | 0.120 |
Why?
|
Autoantibodies | 2 | 2000 | 2115 | 0.120 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 30 | 0.120 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Mutant Proteins | 1 | 2016 | 487 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2017 | 2881 | 0.110 |
Why?
|
Piperazines | 1 | 2004 | 2547 | 0.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 496 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 582 | 0.110 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1463 | 0.110 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 168 | 0.110 |
Why?
|
Protein Binding | 4 | 2017 | 9320 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 10745 | 0.110 |
Why?
|
Blood Protein Electrophoresis | 1 | 2013 | 65 | 0.110 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 1374 | 0.110 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 492 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2016 | 8540 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2018 | 3607 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3250 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 740 | 0.110 |
Why?
|
Translocation, Genetic | 2 | 2021 | 1392 | 0.110 |
Why?
|
Reye Syndrome | 1 | 1992 | 28 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2004 | 1244 | 0.110 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1926 | 0.100 |
Why?
|
Medical Oncology | 2 | 2017 | 2340 | 0.100 |
Why?
|
Molecular Sequence Data | 5 | 2013 | 17608 | 0.100 |
Why?
|
Oxazines | 1 | 2015 | 358 | 0.100 |
Why?
|
Adjuvants, Immunologic | 3 | 2003 | 996 | 0.100 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 646 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 658 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 1604 | 0.100 |
Why?
|
Kupffer Cells | 1 | 1993 | 143 | 0.100 |
Why?
|
Immunoglobulins | 2 | 2017 | 853 | 0.100 |
Why?
|
Remission Induction | 3 | 2014 | 2413 | 0.100 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11094 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 474 | 0.100 |
Why?
|
Drug Resistance | 2 | 2019 | 1592 | 0.100 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1994 | 281 | 0.100 |
Why?
|
Quality of Life | 3 | 2024 | 13476 | 0.100 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1992 | 38 | 0.100 |
Why?
|
Cell Cycle | 4 | 2015 | 2926 | 0.100 |
Why?
|
Stem Cells | 1 | 2005 | 3537 | 0.100 |
Why?
|
Transferrin | 1 | 2013 | 283 | 0.100 |
Why?
|
Electrophoresis, Capillary | 2 | 2009 | 63 | 0.100 |
Why?
|
Cell Communication | 2 | 2018 | 1660 | 0.100 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2012 | 85 | 0.100 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 240 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 614 | 0.090 |
Why?
|
Luciferases | 1 | 2013 | 713 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 716 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2948 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2815 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 460 | 0.090 |
Why?
|
Stomatitis | 1 | 2014 | 271 | 0.090 |
Why?
|
Cell Movement | 6 | 2015 | 5199 | 0.090 |
Why?
|
Base Sequence | 5 | 2016 | 12415 | 0.090 |
Why?
|
Proteomics | 4 | 2017 | 3914 | 0.090 |
Why?
|
Immunoprecipitation | 1 | 2013 | 874 | 0.090 |
Why?
|
Thrombocytopenia | 2 | 2009 | 1172 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 789 | 0.090 |
Why?
|
Hepatitis | 1 | 1992 | 226 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13485 | 0.090 |
Why?
|
Nuclear Proteins | 5 | 2013 | 5795 | 0.090 |
Why?
|
Lentivirus | 1 | 2013 | 518 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 996 | 0.090 |
Why?
|
Ubiquitins | 1 | 2012 | 365 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 405 | 0.090 |
Why?
|
Immunosuppressive Agents | 4 | 2012 | 4215 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 502 | 0.080 |
Why?
|
Drug Evaluation | 1 | 2011 | 642 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1028 | 0.080 |
Why?
|
Methotrexate | 1 | 1996 | 1719 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2022 | 3077 | 0.080 |
Why?
|
Stromal Cells | 4 | 2012 | 1334 | 0.080 |
Why?
|
Blotting, Western | 3 | 2013 | 5022 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 16044 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.080 |
Why?
|
Complementarity Determining Regions | 2 | 2007 | 154 | 0.080 |
Why?
|
Chlorambucil | 1 | 2008 | 42 | 0.080 |
Why?
|
United States | 5 | 2021 | 72951 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2006 | 0.080 |
Why?
|
Antigens, Nuclear | 2 | 2000 | 182 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3804 | 0.080 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9547 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2015 | 21162 | 0.080 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 588 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2012 | 1337 | 0.080 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 11920 | 0.080 |
Why?
|
Bone Marrow Neoplasms | 1 | 2009 | 101 | 0.080 |
Why?
|
Transfection | 5 | 2011 | 5754 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10384 | 0.080 |
Why?
|
Neoplasm Transplantation | 5 | 2014 | 2012 | 0.070 |
Why?
|
Down-Regulation | 6 | 2016 | 2931 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5789 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4400 | 0.070 |
Why?
|
beta Catenin | 2 | 2015 | 1048 | 0.070 |
Why?
|
Morbidity | 1 | 2013 | 1754 | 0.070 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 138 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 633 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1885 | 0.070 |
Why?
|
Genes, p16 | 2 | 1997 | 157 | 0.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2007 | 89 | 0.070 |
Why?
|
Cohort Studies | 3 | 2015 | 41710 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 58 | 0.070 |
Why?
|
Diarrhea | 1 | 2014 | 1317 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1751 | 0.070 |
Why?
|
Splenomegaly | 3 | 2003 | 191 | 0.070 |
Why?
|
Trans-Activators | 3 | 2014 | 2855 | 0.070 |
Why?
|
Herpes Zoster | 1 | 2009 | 252 | 0.070 |
Why?
|
Authorship | 1 | 2010 | 289 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1555 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3464 | 0.070 |
Why?
|
Tumor Burden | 2 | 2014 | 1900 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2014 | 11651 | 0.070 |
Why?
|
Platelet Count | 1 | 2009 | 784 | 0.070 |
Why?
|
Catechin | 1 | 2006 | 69 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3425 | 0.070 |
Why?
|
Microtubules | 1 | 1992 | 1062 | 0.060 |
Why?
|
Models, Genetic | 2 | 2014 | 3450 | 0.060 |
Why?
|
Lymphatic Diseases | 3 | 2003 | 318 | 0.060 |
Why?
|
Genes, Immunoglobulin | 2 | 2004 | 283 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4619 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2101 | 0.060 |
Why?
|
Advisory Committees | 2 | 2022 | 797 | 0.060 |
Why?
|
Interphase | 1 | 2005 | 226 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2057 | 0.060 |
Why?
|
Viral Proteins | 3 | 2002 | 1801 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13278 | 0.060 |
Why?
|
Caspase 9 | 2 | 2002 | 184 | 0.060 |
Why?
|
Age Factors | 4 | 2018 | 18397 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2008 | 1331 | 0.060 |
Why?
|
Conflict of Interest | 1 | 2010 | 556 | 0.060 |
Why?
|
Caspase 8 | 2 | 2002 | 198 | 0.060 |
Why?
|
Cancer Vaccines | 2 | 2004 | 1042 | 0.060 |
Why?
|
Retinoblastoma Protein | 2 | 1999 | 670 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2022 | 4276 | 0.060 |
Why?
|
Protein Folding | 1 | 2008 | 868 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 975 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 1997 | 705 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2013 | 13411 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9404 | 0.060 |
Why?
|
Bone and Bones | 1 | 2014 | 2559 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2006 | 308 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 616 | 0.060 |
Why?
|
VDJ Recombinases | 1 | 2004 | 84 | 0.060 |
Why?
|
DNA Helicases | 2 | 2000 | 853 | 0.060 |
Why?
|
Up-Regulation | 6 | 2007 | 4142 | 0.060 |
Why?
|
Disclosure | 1 | 2010 | 755 | 0.060 |
Why?
|
Genetic Variation | 3 | 2016 | 6612 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 923 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2717 | 0.060 |
Why?
|
Karyotyping | 1 | 2005 | 1176 | 0.060 |
Why?
|
Receptors, Interleukin-6 | 3 | 2004 | 227 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11218 | 0.060 |
Why?
|
Caspase 3 | 2 | 2016 | 730 | 0.050 |
Why?
|
Immunoglobulin delta-Chains | 1 | 2003 | 7 | 0.050 |
Why?
|
Immunoglobulin J-Chains | 1 | 2003 | 26 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2006 | 695 | 0.050 |
Why?
|
Cell Death | 3 | 2016 | 1676 | 0.050 |
Why?
|
Drug Industry | 1 | 2010 | 791 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2846 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 472 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2024 | 411 | 0.050 |
Why?
|
Codon | 1 | 2005 | 599 | 0.050 |
Why?
|
Pyridines | 1 | 2015 | 2888 | 0.050 |
Why?
|
International Classification of Diseases | 1 | 2009 | 935 | 0.050 |
Why?
|
Risk Factors | 9 | 2019 | 74881 | 0.050 |
Why?
|
Cryoglobulinemia | 1 | 2003 | 84 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3796 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2003 | 318 | 0.050 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 46 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 185 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2007 | 1206 | 0.050 |
Why?
|
Neutralization Tests | 2 | 2001 | 735 | 0.050 |
Why?
|
Sulfones | 1 | 2004 | 447 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2012 | 1012 | 0.050 |
Why?
|
Enzyme Precursors | 1 | 2002 | 166 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4652 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2002 | 114 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4055 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2016 | 428 | 0.050 |
Why?
|
Splenectomy | 1 | 2003 | 390 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1362 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2006 | 3738 | 0.050 |
Why?
|
Macrophages | 2 | 1994 | 5783 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10619 | 0.050 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2002 | 200 | 0.050 |
Why?
|
Cyclins | 3 | 1999 | 605 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2000 | 457 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11061 | 0.050 |
Why?
|
Lectins | 1 | 2003 | 490 | 0.050 |
Why?
|
Bone Marrow Transplantation | 2 | 2006 | 2730 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2902 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5182 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2004 | 1935 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3236 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2005 | 910 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 2001 | 215 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2004 | 2747 | 0.040 |
Why?
|
Recombinant Proteins | 5 | 2003 | 6507 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2003 | 647 | 0.040 |
Why?
|
Liver | 2 | 1993 | 7571 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8735 | 0.040 |
Why?
|
Immunomagnetic Separation | 1 | 2000 | 78 | 0.040 |
Why?
|
G1 Phase | 2 | 2000 | 403 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4860 | 0.040 |
Why?
|
Leukocytes | 1 | 2008 | 2035 | 0.040 |
Why?
|
Phospholipase C gamma | 1 | 2020 | 130 | 0.040 |
Why?
|
DNA Damage | 2 | 2018 | 2467 | 0.040 |
Why?
|
src-Family Kinases | 1 | 2022 | 539 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2000 | 255 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2746 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4443 | 0.040 |
Why?
|
Treatment Failure | 2 | 2021 | 2659 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 671 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7074 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 663 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 2 | 2010 | 161 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 379 | 0.040 |
Why?
|
Propidium | 1 | 1998 | 42 | 0.040 |
Why?
|
Lymphocyte Activation | 3 | 2005 | 5503 | 0.040 |
Why?
|
Pain | 1 | 2014 | 5098 | 0.040 |
Why?
|
Viral Core Proteins | 1 | 1999 | 158 | 0.040 |
Why?
|
Toremifene | 1 | 1998 | 26 | 0.040 |
Why?
|
Lymphokines | 1 | 2001 | 924 | 0.040 |
Why?
|
Indoles | 1 | 2007 | 1834 | 0.040 |
Why?
|
Clone Cells | 2 | 2016 | 1670 | 0.040 |
Why?
|
Pneumocystis carinii | 1 | 2018 | 71 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2660 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2004 | 1437 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2005 | 1895 | 0.040 |
Why?
|
Rad51 Recombinase | 1 | 2018 | 191 | 0.040 |
Why?
|
Massachusetts | 1 | 2011 | 8891 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2016 | 747 | 0.040 |
Why?
|
Leukemia, Plasma Cell | 1 | 1997 | 46 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 678 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2007 | 7609 | 0.040 |
Why?
|
Hemodynamics | 1 | 2008 | 4188 | 0.040 |
Why?
|
Phosphorylcholine | 2 | 2008 | 152 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 231 | 0.040 |
Why?
|
Myeloma Proteins | 1 | 2017 | 71 | 0.030 |
Why?
|
Drug Discovery | 2 | 2016 | 1065 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2004 | 1377 | 0.030 |
Why?
|
Risk Assessment | 4 | 2024 | 24295 | 0.030 |
Why?
|
Pneumonia | 1 | 2008 | 2159 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1999 | 638 | 0.030 |
Why?
|
Plasmacytoma | 2 | 2011 | 171 | 0.030 |
Why?
|
Graft Survival | 1 | 2007 | 3904 | 0.030 |
Why?
|
Autoantigens | 1 | 2000 | 886 | 0.030 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2000 | 245 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2827 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1327 | 0.030 |
Why?
|
Young Adult | 2 | 2014 | 59939 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2016 | 5143 | 0.030 |
Why?
|
London | 1 | 2016 | 233 | 0.030 |
Why?
|
Lung | 1 | 2014 | 10067 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2016 | 1525 | 0.030 |
Why?
|
Coloring Agents | 1 | 1998 | 565 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2002 | 2870 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2017 | 3552 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 1997 | 301 | 0.030 |
Why?
|
Integrin alpha4beta1 | 1 | 2015 | 119 | 0.030 |
Why?
|
Growth Substances | 1 | 1998 | 759 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2000 | 1615 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2000 | 1646 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2004 | 1352 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3944 | 0.030 |
Why?
|
Bence Jones Protein | 2 | 2006 | 19 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2764 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2004 | 478 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1345 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 540 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2006 | 1642 | 0.030 |
Why?
|
Serologic Tests | 1 | 2017 | 382 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 3 | 2010 | 1852 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1741 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 1996 | 234 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2004 | 1805 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 685 | 0.030 |
Why?
|
Epitopes | 1 | 2000 | 2526 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1997 | 661 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2258 | 0.030 |
Why?
|
Exosomes | 1 | 2018 | 417 | 0.030 |
Why?
|
Tamoxifen | 1 | 1998 | 967 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 447 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 605 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1054 | 0.030 |
Why?
|
Lactams, Macrocyclic | 2 | 2007 | 319 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2228 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4913 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 692 | 0.030 |
Why?
|
Electrophoresis | 1 | 2013 | 226 | 0.030 |
Why?
|
Monokines | 1 | 1992 | 71 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2012 | 91 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2000 | 1384 | 0.030 |
Why?
|
Densitometry | 1 | 2012 | 150 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2012 | 155 | 0.030 |
Why?
|
Salmonella | 1 | 1993 | 125 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 569 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2007 | 422 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 2 | 2004 | 419 | 0.020 |
Why?
|
Salivary Glands | 1 | 2013 | 231 | 0.020 |
Why?
|
ras Proteins | 1 | 1997 | 1055 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6222 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 1999 | 439 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10264 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3609 | 0.020 |
Why?
|
Morpholines | 1 | 2015 | 584 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 515 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2017 | 1787 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3342 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 2 | 2007 | 3408 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 1947 | 0.020 |
Why?
|
Fibrosarcoma | 1 | 1993 | 313 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3053 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3070 | 0.020 |
Why?
|
Protein Kinases | 1 | 1997 | 1610 | 0.020 |
Why?
|
Osteolysis | 1 | 2012 | 273 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1996 | 962 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2251 | 0.020 |
Why?
|
Focal Adhesion Kinase 2 | 2 | 2000 | 87 | 0.020 |
Why?
|
Peptides | 1 | 2002 | 4344 | 0.020 |
Why?
|
Receptors, Interleukin-17 | 1 | 2010 | 82 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 872 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 474 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1729 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1057 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1504 | 0.020 |
Why?
|
STAT2 Transcription Factor | 2 | 2000 | 27 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1993 | 1030 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2016 | 12791 | 0.020 |
Why?
|
Cytokine Receptor gp130 | 2 | 2000 | 66 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4924 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1110 | 0.020 |
Why?
|
Plasmids | 1 | 2014 | 2268 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2011 | 1062 | 0.020 |
Why?
|
Janus Kinase 1 | 2 | 2000 | 108 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2009 | 162 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1560 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2008 | 110 | 0.020 |
Why?
|
Osteoclasts | 1 | 2012 | 713 | 0.020 |
Why?
|
Biological Transport | 1 | 1993 | 2083 | 0.020 |
Why?
|
DNA, Viral | 3 | 2000 | 2201 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 962 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2016 | 20708 | 0.020 |
Why?
|
International Agencies | 1 | 2008 | 244 | 0.020 |
Why?
|
STAT1 Transcription Factor | 2 | 2000 | 340 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1082 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12430 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6012 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1007 | 0.020 |
Why?
|
Receptors, Laminin | 1 | 2006 | 26 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2594 | 0.020 |
Why?
|
Bone Transplantation | 2 | 2005 | 921 | 0.020 |
Why?
|
Benzoquinones | 1 | 2007 | 198 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2007 | 381 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2022 | 14471 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9346 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2007 | 464 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2593 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5386 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.020 |
Why?
|
Introns | 1 | 2008 | 966 | 0.020 |
Why?
|
Lactones | 1 | 2008 | 316 | 0.020 |
Why?
|
Janus Kinase 2 | 2 | 2000 | 562 | 0.020 |
Why?
|
Ligands | 2 | 2002 | 3275 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1040 | 0.020 |
Why?
|
Stimulation, Chemical | 1 | 2005 | 305 | 0.010 |
Why?
|
Drug Interactions | 2 | 2001 | 1419 | 0.010 |
Why?
|
Family | 1 | 2016 | 3209 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2005 | 317 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 2 | 1997 | 462 | 0.010 |
Why?
|
Tea | 1 | 2006 | 289 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 830 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14652 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 294 | 0.010 |
Why?
|
Syndecans | 1 | 2004 | 75 | 0.010 |
Why?
|
Monocytes | 1 | 1994 | 2600 | 0.010 |
Why?
|
Phytotherapy | 1 | 2006 | 297 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2795 | 0.010 |
Why?
|
RNA Splicing | 1 | 2008 | 903 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2004 | 511 | 0.010 |
Why?
|
Cell Fusion | 1 | 2004 | 294 | 0.010 |
Why?
|
Forecasting | 1 | 2012 | 2936 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 210 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2005 | 861 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 2005 | 565 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2012 | 2060 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2005 | 321 | 0.010 |
Why?
|
Syndecan-1 | 1 | 2004 | 163 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 925 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4539 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 283 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2005 | 392 | 0.010 |
Why?
|
Exons | 1 | 2008 | 2392 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15416 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10580 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2002 | 123 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4018 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8106 | 0.010 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2002 | 324 | 0.010 |
Why?
|
Pyrroles | 1 | 2008 | 1121 | 0.010 |
Why?
|
Cell Separation | 1 | 2007 | 1718 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2003 | 399 | 0.010 |
Why?
|
Fluorescence | 1 | 2003 | 751 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2000 | 43 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2003 | 839 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 806 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 121 | 0.010 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2000 | 111 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 339 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1006 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 542 | 0.010 |
Why?
|
src Homology Domains | 1 | 2000 | 361 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2006 | 1469 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 224 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2001 | 591 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2000 | 261 | 0.010 |
Why?
|
International Cooperation | 1 | 2006 | 1434 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2000 | 740 | 0.010 |
Why?
|
Cyclin D | 1 | 1999 | 71 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2001 | 794 | 0.010 |
Why?
|
Melphalan | 1 | 2000 | 425 | 0.010 |
Why?
|
Hybridomas | 1 | 2000 | 442 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 588 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 1999 | 251 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 2002 | 792 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2004 | 1250 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2000 | 699 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2000 | 330 | 0.010 |
Why?
|
Antigens | 1 | 2004 | 1441 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1560 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2062 | 0.010 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 1997 | 46 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2572 | 0.010 |
Why?
|
Cyclin D2 | 1 | 1997 | 97 | 0.010 |
Why?
|
TYK2 Kinase | 1 | 1997 | 38 | 0.010 |
Why?
|
SOS1 Protein | 1 | 1997 | 40 | 0.010 |
Why?
|
Gamma Rays | 1 | 1999 | 324 | 0.010 |
Why?
|
Ubiquitin | 1 | 2002 | 841 | 0.010 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 1998 | 250 | 0.010 |
Why?
|
Genes, p53 | 1 | 2000 | 711 | 0.010 |
Why?
|
GRB2 Adaptor Protein | 1 | 1997 | 101 | 0.010 |
Why?
|
Aging | 1 | 1996 | 8731 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 816 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1999 | 609 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1997 | 128 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 635 | 0.010 |
Why?
|
Fetal Tissue Transplantation | 1 | 1997 | 139 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2629 | 0.010 |
Why?
|
Flavonoids | 1 | 2000 | 447 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2210 | 0.010 |
Why?
|
Rats | 1 | 1993 | 23717 | 0.010 |
Why?
|
Child | 2 | 1996 | 80668 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1997 | 376 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6550 | 0.010 |
Why?
|
Imidazoles | 1 | 2002 | 1168 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2002 | 1319 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7241 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2003 | 2198 | 0.010 |
Why?
|
Thiazoles | 1 | 2003 | 1529 | 0.010 |
Why?
|
Tyrosine | 1 | 2000 | 1425 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 1997 | 361 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2002 | 1627 | 0.010 |
Why?
|
Fibronectins | 1 | 1998 | 722 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1997 | 562 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1826 | 0.010 |
Why?
|
DNA Replication | 1 | 2000 | 1426 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1997 | 572 | 0.010 |
Why?
|
Cytoplasm | 1 | 1998 | 1505 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1997 | 901 | 0.010 |
Why?
|
Cost of Illness | 1 | 2003 | 1949 | 0.010 |
Why?
|
Temperature | 1 | 2000 | 2233 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6287 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1997 | 1206 | 0.010 |
Why?
|
Proteins | 2 | 1997 | 6002 | 0.010 |
Why?
|
Antibodies | 1 | 2000 | 2421 | 0.010 |
Why?
|
Weight Loss | 1 | 2003 | 2712 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2001 | 3511 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7208 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20144 | 0.000 |
Why?
|
Cell Membrane | 1 | 1998 | 3641 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15908 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1997 | 4891 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1997 | 2978 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7475 | 0.000 |
Why?
|